125 related articles for article (PubMed ID: 27571219)
1. Structure-Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX Chromodomains.
Stuckey JI; Simpson C; Norris-Drouin JL; Cholensky SH; Lee J; Pasca R; Cheng N; Dickson BM; Pearce KH; Frye SV; James LI
J Med Chem; 2016 Oct; 59(19):8913-8923. PubMed ID: 27571219
[TBL] [Abstract][Full Text] [Related]
2. The molecular selectivity of UNC3866 inhibitor for Polycomb CBX7 protein from molecular dynamics simulation.
Liu H; Li Z; Li L
Comput Biol Chem; 2018 Jun; 74():339-346. PubMed ID: 29723807
[TBL] [Abstract][Full Text] [Related]
3. A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1.
Stuckey JI; Dickson BM; Cheng N; Liu Y; Norris JL; Cholensky SH; Tempel W; Qin S; Huber KG; Sagum C; Black K; Li F; Huang XP; Roth BL; Baughman BM; Senisterra G; Pattenden SG; Vedadi M; Brown PJ; Bedford MT; Min J; Arrowsmith CH; James LI; Frye SV
Nat Chem Biol; 2016 Mar; 12(3):180-7. PubMed ID: 26807715
[TBL] [Abstract][Full Text] [Related]
4. Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7).
Simhadri C; Daze KD; Douglas SF; Quon TT; Dev A; Gignac MC; Peng F; Heller M; Boulanger MJ; Wulff JE; Hof F
J Med Chem; 2014 Apr; 57(7):2874-83. PubMed ID: 24625057
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor.
Wang S; Denton KE; Hobbs KF; Weaver T; McFarlane JMB; Connelly KE; Gignac MC; Milosevich N; Hof F; Paci I; Musselman CA; Dykhuizen EC; Krusemark CJ
ACS Chem Biol; 2020 Jan; 15(1):112-131. PubMed ID: 31755685
[TBL] [Abstract][Full Text] [Related]
6. Polycomb Paralog Chromodomain Inhibitors Active against Both CBX6 and CBX8*.
Milosevich N; Wilson CR; Brown TM; Alpsoy A; Wang S; Connelly KE; Sinclair KAD; Ponio FR; Hof R; Dykhuizen EC; Hof F
ChemMedChem; 2021 Oct; 16(19):3027-3034. PubMed ID: 34174168
[TBL] [Abstract][Full Text] [Related]
7. Chromodomain Ligand Optimization via Target-Class Directed Combinatorial Repurposing.
Barnash KD; Lamb KN; Stuckey JI; Norris JL; Cholensky SH; Kireev DB; Frye SV; James LI
ACS Chem Biol; 2016 Sep; 11(9):2475-83. PubMed ID: 27356154
[TBL] [Abstract][Full Text] [Related]
8. Structure-Activity Relationships of Cbx7 Inhibitors, Including Selectivity Studies against Other Cbx Proteins.
Simhadri C; Gignac MC; Anderson CJ; Milosevich N; Dheri A; Prashar N; Flemmer RT; Dev A; Henderson TG; Douglas SF; Wulff JE; Hof F
ACS Omega; 2016 Oct; 1(4):541-551. PubMed ID: 30023485
[TBL] [Abstract][Full Text] [Related]
9. Rational Adaptation of L3MBTL1 Inhibitors to Create Small-Molecule Cbx7 Antagonists.
Simhadri C; Daze KD; Douglas SF; Milosevich N; Monjas L; Dev A; Brown TM; Hirsch AKH; Wulff JE; Hof F
ChemMedChem; 2019 Aug; 14(15):1444-1456. PubMed ID: 31254321
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain.
Ren C; Morohashi K; Plotnikov AN; Jakoncic J; Smith SG; Li J; Zeng L; Rodriguez Y; Stojanoff V; Walsh M; Zhou MM
Chem Biol; 2015 Feb; 22(2):161-8. PubMed ID: 25660273
[TBL] [Abstract][Full Text] [Related]
11. Live-cell single-molecule tracking reveals co-recognition of H3K27me3 and DNA targets polycomb Cbx7-PRC1 to chromatin.
Zhen CY; Tatavosian R; Huynh TN; Duc HN; Das R; Kokotovic M; Grimm JB; Lavis LD; Lee J; Mejia FJ; Li Y; Yao T; Ren X
Elife; 2016 Oct; 5():. PubMed ID: 27723458
[TBL] [Abstract][Full Text] [Related]
12. Robustness of In Vitro Selection Assays of DNA-Encoded Peptidomimetic Ligands to CBX7 and CBX8.
Denton KE; Wang S; Gignac MC; Milosevich N; Hof F; Dykhuizen EC; Krusemark CJ
SLAS Discov; 2018 Jun; 23(5):417-428. PubMed ID: 29309209
[TBL] [Abstract][Full Text] [Related]
13. Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3.
James LI; Korboukh VK; Krichevsky L; Baughman BM; Herold JM; Norris JL; Jin J; Kireev DB; Janzen WP; Arrowsmith CH; Frye SV
J Med Chem; 2013 Sep; 56(18):7358-71. PubMed ID: 24040942
[TBL] [Abstract][Full Text] [Related]
14. Ring1B contains a ubiquitin-like docking module for interaction with Cbx proteins.
Bezsonova I; Walker JR; Bacik JP; Duan S; Dhe-Paganon S; Arrowsmith CH
Biochemistry; 2009 Nov; 48(44):10542-8. PubMed ID: 19791798
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of 2-substituted D-tryptophan-containing peptidic endothelin receptor antagonists: importance of the C-2 substituent of the D-tryptophan residue for endothelin A and B receptor subtype selectivity.
Fukami T; Yamakawa T; Niiyama K; Kojima H; Amano Y; Kanda F; Ozaki S; Fukuroda T; Ihara M; Yano M; Ishikawa K
J Med Chem; 1996 Jun; 39(12):2313-30. PubMed ID: 8691426
[TBL] [Abstract][Full Text] [Related]
16. Binding inhibitors of the bacterial sliding clamp by design.
Wijffels G; Johnson WM; Oakley AJ; Turner K; Epa VC; Briscoe SJ; Polley M; Liepa AJ; Hofmann A; Buchardt J; Christensen C; Prosselkov P; Dalrymple BP; Alewood PF; Jennings PA; Dixon NE; Winkler DA
J Med Chem; 2011 Jul; 54(13):4831-8. PubMed ID: 21604761
[TBL] [Abstract][Full Text] [Related]
17. CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway.
Kim HY; Park JH; Won HY; Lee JY; Kong G
FASEB J; 2015 Jan; 29(1):300-13. PubMed ID: 25351982
[TBL] [Abstract][Full Text] [Related]
18. Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent.
Somvanshi RK; Kumar A; Kant S; Gupta D; Singh SB; Das U; Srinivasan A; Singh TP; Dey S
Biochem Biophys Res Commun; 2007 Sep; 361(1):37-42. PubMed ID: 17640617
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketones.
Cregge RJ; Durham SL; Farr RA; Gallion SL; Hare CM; Hoffman RV; Janusz MJ; Kim HO; Koehl JR; Mehdi S; Metz WA; Peet NP; Pelton JT; Schreuder HA; Sunder S; Tardif C
J Med Chem; 1998 Jul; 41(14):2461-80. PubMed ID: 9651152
[TBL] [Abstract][Full Text] [Related]
20. Pan-specific and partially selective dye-labeled peptidic inhibitors of the polycomb paralog proteins.
Milosevich N; McFarlane J; Gignac MC; Li J; Brown TM; Wilson CR; Devorkin L; Croft CS; Hof R; Paci I; Lum JJ; Hof F
Bioorg Med Chem; 2020 Jan; 28(1):115176. PubMed ID: 31753799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
